West Pharmaceutical Services, Inc. (BVMF:W2ST34)
34.50
-0.30 (-0.86%)
At close: Feb 3, 2026
BVMF:W2ST34 Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 791.3 | 484.6 | 853.9 | 894.3 | 762.6 | Upgrade
|
| Cash & Short-Term Investments | 791.3 | 484.6 | 853.9 | 894.3 | 762.6 | Upgrade
|
| Cash Growth | 63.29% | -43.25% | -4.52% | 17.27% | 23.90% | Upgrade
|
| Receivables | 586.3 | 575.8 | 533.5 | 523.7 | 503.6 | Upgrade
|
| Inventory | 443.9 | 377 | 434.7 | 414.8 | 378.4 | Upgrade
|
| Other Current Assets | 156.7 | 100.7 | 114.3 | 86.7 | 97.4 | Upgrade
|
| Total Current Assets | 1,978 | 1,538 | 1,936 | 1,920 | 1,742 | Upgrade
|
| Property, Plant & Equipment | 1,878 | 1,716 | 1,513 | 1,263 | 1,127 | Upgrade
|
| Long-Term Investments | 212.3 | 202.1 | 210 | 204.9 | 207.7 | Upgrade
|
| Goodwill | 109.9 | 106 | 108.5 | 107.3 | 109.9 | Upgrade
|
| Other Intangible Assets | 7.7 | 10.8 | 15.1 | 18.4 | 23 | Upgrade
|
| Long-Term Deferred Tax Assets | 38.4 | 26 | 25.7 | 65.6 | 48.5 | Upgrade
|
| Other Long-Term Assets | 45.4 | 44.6 | 21.3 | 38.4 | 55.9 | Upgrade
|
| Total Assets | 4,270 | 3,643 | 3,830 | 3,617 | 3,314 | Upgrade
|
| Accounts Payable | 253.7 | 239.3 | 242.4 | 215.4 | 232.2 | Upgrade
|
| Accrued Expenses | 214.6 | 138 | 161.3 | 145.8 | 186.1 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 134 | 2.2 | 44.2 | Upgrade
|
| Current Portion of Leases | 24.2 | 18.8 | 17.7 | 16 | 9.3 | Upgrade
|
| Current Income Taxes Payable | 28.1 | 31.5 | 16.6 | 24.8 | 26.3 | Upgrade
|
| Current Unearned Revenue | 51.9 | 49.6 | 41.7 | 57.3 | 48.7 | Upgrade
|
| Other Current Liabilities | 82.4 | 73.2 | 58.1 | 57.5 | 47.3 | Upgrade
|
| Total Current Liabilities | 654.9 | 550.4 | 671.8 | 519 | 594.1 | Upgrade
|
| Long-Term Debt | 202.8 | 202.6 | 72.8 | 206.7 | 208.8 | Upgrade
|
| Long-Term Leases | 99.2 | 83.9 | 84.5 | 93 | 63 | Upgrade
|
| Long-Term Unearned Revenue | 1.8 | 3.6 | 12.2 | 10.9 | - | Upgrade
|
| Pension & Post-Retirement Benefits | 29 | 28.2 | 29.6 | 28.2 | 40.5 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 23 | 20.5 | 12.7 | 14.3 | 4.9 | Upgrade
|
| Other Long-Term Liabilities | 83.3 | 71.9 | 64.9 | 59.8 | 67.1 | Upgrade
|
| Total Liabilities | 1,094 | 961.1 | 948.5 | 931.9 | 978.4 | Upgrade
|
| Common Stock | 18.8 | 18.8 | 18.8 | 18.8 | 18.8 | Upgrade
|
| Additional Paid-In Capital | - | 22.1 | 120.2 | 232.2 | 249 | Upgrade
|
| Retained Earnings | 4,375 | 3,957 | 3,523 | 2,988 | 2,457 | Upgrade
|
| Treasury Stock | -1,112 | -1,057 | -637.6 | -370.9 | -229.5 | Upgrade
|
| Comprehensive Income & Other | -105.5 | -258.1 | -143.8 | -183 | -159.6 | Upgrade
|
| Shareholders' Equity | 3,176 | 2,682 | 2,881 | 2,685 | 2,335 | Upgrade
|
| Total Liabilities & Equity | 4,270 | 3,643 | 3,830 | 3,617 | 3,314 | Upgrade
|
| Total Debt | 326.2 | 305.3 | 309 | 317.9 | 325.3 | Upgrade
|
| Net Cash (Debt) | 465.1 | 179.3 | 544.9 | 576.4 | 437.3 | Upgrade
|
| Net Cash Growth | 159.40% | -67.09% | -5.46% | 31.81% | 53.87% | Upgrade
|
| Net Cash Per Share | 6.40 | 2.43 | 7.24 | 7.60 | 5.73 | Upgrade
|
| Filing Date Shares Outstanding | 72.02 | 72.3 | 73.3 | 74.14 | 74.28 | Upgrade
|
| Total Common Shares Outstanding | 72 | 72.3 | 73.5 | 74.1 | 74.2 | Upgrade
|
| Working Capital | 1,323 | 987.7 | 1,265 | 1,401 | 1,148 | Upgrade
|
| Book Value Per Share | 44.11 | 37.10 | 39.20 | 36.23 | 31.47 | Upgrade
|
| Tangible Book Value | 3,058 | 2,566 | 2,757 | 2,559 | 2,203 | Upgrade
|
| Tangible Book Value Per Share | 42.48 | 35.48 | 37.52 | 34.54 | 29.68 | Upgrade
|
| Land | 29.2 | 27.9 | 33.7 | 29 | 29.3 | Upgrade
|
| Buildings | 1,181 | 916.1 | 771.5 | 663.6 | 644.8 | Upgrade
|
| Machinery | 1,757 | 1,631 | 1,518 | 1,388 | 1,298 | Upgrade
|
| Construction In Progress | 256.7 | 410.8 | 415.2 | 305.9 | 242.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.